The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity.
about
Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: an exploration of nutrition indices among nomadic and recently settled Ariaal men of northern KenyaIs there an effect of ghrelin/ghrelin analogs on cancer? A systematic reviewInsulin-like growth factor-1 deficiency and metabolic syndromeMenopause, the metabolic syndrome, and mind-body therapiesStudy Protocol: insulin and its role in cancerUse of Pegvisomant in acromegaly. An Italian Society of Endocrinology guidelineThe trajectory of IGF-1 across age and duration of type 1 diabetesAltered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndromeIntense Walking Exercise Affects Serum IGF-1 and IGFBP3.IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition.Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly.Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly.Early growth conditions, phenotypic development and environmental change.Growth hormone is a cellular senescence target in pituitary and nonpituitary cellsThe acid-labile subunit is required for full effects of exogenous growth hormone on growth and carbohydrate metabolismNon-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscleRecent Insights into Insulin-Like Growth Factor Binding Protein 2 Transcriptional Regulation.Energy intake correlates with the levels of fatty acid synthase and insulin-like growth factor-1 in male and female C57BL/6 mice.New therapeutic agents for acromegaly.Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR.Fractones: extracellular matrix niche controlling stem cell fate and growth factor activity in the brain in health and disease.Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy.Partial IGF-1 deficiency is sufficient to reduce heart contractibility, angiotensin II sensibility, and alter gene expression of structural and functional cardiac proteins.Lifetime congenital isolated GH deficiency does not protect from the development of diabetes.A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly.Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice.Association between insulin-like growth factor-1, measures of overnutrition and undernutrition and insulin resistance in black adolescents living in the North-West Province, South Africa.Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis.Benefits of Nut Consumption on Insulin Resistance and Cardiovascular Risk Factors: Multiple Potential Mechanisms of Actions.Serum ghrelin levels in papillary thyroid carcinoma.Evaluation of the safety of daily administration of capromorelin in cats.The preliminary study on the effects of growth hormone and insulin-like growth factor-I on κ-casein synthesis in bovine mammary epithelial cells in vitro.CCL2, CCL5, and IGF-1 participate in the immunomodulation of osteogenesis during M1/M2 transition in vitro.Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes.Functional Variants Identified Efficiently through an Integrated Transcriptome and Epigenome Analysis.Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide.Nutrient utilisation, growth performance and blood metabolites in Murrah buffalo calves (Bubalus bubalis) divergently selected for residual feed intake.The Growth Hormone Receptor: Mechanism of Receptor Activation, Cell Signaling, and Physiological Aspects.Insulin-Like Growth Factor (IGF) System in Liver Diseases.
P2860
Q21283889-270FF05C-2BD5-43F7-B133-42B80E103EDCQ26739709-068285CD-6B81-455E-8EF1-A6C52A2C4FF4Q28072410-2CFEA246-0258-47B1-B00F-763FDAD307E9Q30437308-45519F0A-9FCC-4E9A-A9F2-39E11A8D35D2Q33303492-CC75BBF9-CD23-41D9-A4AC-5D7D3B11566BQ34277844-826EB54B-AF6C-47CE-BC35-9D34A643DC0CQ34536262-7583FF41-E82E-4056-B868-46EFF53A9A0CQ36159564-FB2E7C4A-100E-474F-B7BF-D80F9394C2EFQ36169204-5531E9D8-5C5A-4B8C-AD72-7A836752A690Q36202868-5FA8BBA3-3505-4890-8576-8D54CF1C6F83Q36732644-B6C59C9D-676C-4FAF-9A99-66E9AA3277B5Q36755284-CA551C47-1A8A-4C78-86F2-0D6335113A4CQ36990184-1FFB7BFC-B01C-44B9-A993-D5C4E0950E3BQ37019548-82421E74-FD43-43CD-83D7-A549C5E98F7CQ37143459-D4D520CF-E70A-49B3-8C84-1286A1F460DEQ37244613-44C93AF8-EDED-44C5-B976-5133F542908DQ37703491-BC443628-F04B-4971-BD51-90340686DCBDQ37723228-4D5F5835-9DEB-4AFA-8632-09A81D111137Q37732928-F41FE019-8867-42EA-B5CE-F59B91762579Q38648739-33C7137B-7D7F-44B9-9595-6D9A2173C7CDQ38912799-8E5A62A1-EB7A-4711-AAEF-8303355D1E68Q38913817-4A206286-E0ED-45F2-B525-37F8395EEFACQ40986521-F29B187D-7B93-454D-8EF4-93DE7CE781F9Q41383801-22C5D757-6655-4F13-A703-97E57F1AC824Q41776005-D64010F8-C809-4970-8A7E-C2FA8800279AQ42171156-569405C6-8DC6-4C8D-9A36-4548D72859FEQ42478447-E3B398D6-CFF6-4564-8844-261AA5A1D982Q43689073-6D647801-353F-480B-BB30-1F1A241FF212Q45305677-38B5D0D7-73BD-49ED-B865-63A3736FACB8Q47161157-8F655EB0-CF94-4F80-9819-E6B055A5FBA6Q47620309-EAFA34F8-0E48-46BC-A989-317686094880Q47732033-03A13C9F-35EE-42E5-BBF7-30B963D92CF9Q47920588-C6EE7A49-2DD7-4B95-986C-E5B7D61C9CACQ47985364-E521F1AD-D95F-49D3-9233-BD33887D4A57Q49480728-E78CA483-FB95-4626-99D8-DF720E15FB22Q50025790-6550503E-8B80-40B1-97E0-D4BA7D28FE0FQ51365761-57B0A511-7E89-4C20-B879-8939B782A9B9Q51463759-ADACC0FE-F702-4946-99F2-198FBEFB325AQ51766789-389AA440-6D63-4A3D-BB2F-459450CC919CQ52558393-1A9ECCC5-0FDF-4801-8477-BB604533F549
P2860
The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity.
@en
type
label
The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity.
@en
prefLabel
The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity.
@en
P2860
P356
P1476
The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity.
@en
P2093
David R Clemmons
P2860
P356
10.1172/JCI20660
P407
P577
2004-01-01T00:00:00Z